1	Tyrphostin	Tyrphostin	_	_	_	_	_	_	_
2	AG-490	AG-490	_	_	_	_	_	_	_
3	inhibits	inhibit	_	_	_	_	_	_	_
4	cytokine-mediated	cytokine-mediated	_	_	_	_	_	_	_
5	JAK3/STAT5a/b	JAK3/STAT5a/b	_	_	_	_	_	_	_
6	signal	signal	_	_	_	_	_	_	_
7	transduction	transduction	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	cellular	cellular	_	_	_	_	_	_	_
10	proliferation	proliferation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	antigen-activated	antigen-activated	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Janus	Janus	_	_	_	_	_	_	_
2	kinase	kinase	_	_	_	_	_	_	_
3	3	3	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	JAK3	jak3	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
10	tyrosine	tyrosine	_	_	_	_	_	_	_
11	kinase	kinase	_	_	_	_	_	_	_
12	required	require	_	_	_	_	_	_	_
13	for	for	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	development	development	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	activated	activate	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	cytokines	cytokine	_	_	_	_	_	_	_
21	that	that	_	_	_	_	_	_	_
22	utilize	utilize	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	interleukin-2	interleukin-2	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	IL-2	il-2	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	receptor	receptor	_	_	_	_	_	_	_
29	common	common	_	_	_	_	_	_	_
30	gamma	gamma	_	_	_	_	_	_	_
31	chain	chain	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	gamma(c))	gamma(c))	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Genetic	genetic	_	_	_	_	_	_	_
2	inactivation	inactivation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	JAK3	JAK3	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	manifested	manifest	_	_	_	_	_	_	_
7	as	as	_	_	_	_	_	_	_
8	severe	severe	_	_	_	_	_	_	_
9	combined	combined	_	_	_	_	_	_	_
10	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
11	disease	disease	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	SCID	SCID	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	humans	human	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	mice	mouse	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	findings	finding	_	_	_	_	_	_	_
3	have	have	_	_	_	_	_	_	_
4	suggested	suggest	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	JAK3	JAK3	_	_	_	_	_	_	_
7	represents	represent	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	pharmacological	pharmacological	_	_	_	_	_	_	_
10	target	target	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	control	control	_	_	_	_	_	_	_
13	certain	certain	_	_	_	_	_	_	_
14	lymphoid-derived	lymphoid-derived	_	_	_	_	_	_	_
15	diseases	disease	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	provide	provide	_	_	_	_	_	_	_
4	novel	novel	_	_	_	_	_	_	_
5	evidence	evidence	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	AG-490	AG-490	_	_	_	_	_	_	_
8	potently	potently	_	_	_	_	_	_	_
9	inhibits	inhibit	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	autokinase	autokinase	_	_	_	_	_	_	_
12	activity	activity	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	JAK3	jak3	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	tyrosine	tyrosine	_	_	_	_	_	_	_
17	phosphorylation	phosphorylation	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	DNA	dna	_	_	_	_	_	_	_
20	binding	binding	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	signal	signal	_	_	_	_	_	_	_
23	transducer	transducer	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	activator	activator	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	transcription	transcription	_	_	_	_	_	_	_
28	5a	5a	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	5b	5b	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	STAT5a/b	STAT5a/b	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Similar	similar	_	_	_	_	_	_	_
2	inhibitory	inhibitory	_	_	_	_	_	_	_
3	effects	effect	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	observed	observe	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	other	other	_	_	_	_	_	_	_
8	cytokines	cytokine	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	use	use	_	_	_	_	_	_	_
11	gamma(c)	gamma(c)	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	AG-490	AG-490	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	inhibited	inhibit	_	_	_	_	_	_	_
4	IL-2-mediated	il-2-mediated	_	_	_	_	_	_	_
5	proliferative	proliferative	_	_	_	_	_	_	_
6	growth	growth	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	an	an	_	_	_	_	_	_	_
13	IC50	ic50	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	=	=	_	_	_	_	_	_	_
16	25	25	_	_	_	_	_	_	_
17	microM	microm	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	was	be	_	_	_	_	_	_	_
20	partially	partially	_	_	_	_	_	_	_
21	recoverable	recoverable	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Moreover	moreover	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	demonstrate	demonstrate	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	this	this	_	_	_	_	_	_	_
7	inhibitor	inhibitor	_	_	_	_	_	_	_
8	prevented	prevent	_	_	_	_	_	_	_
9	tetanus	tetanus	_	_	_	_	_	_	_
10	toxoid	toxoid	_	_	_	_	_	_	_
11	antigen-specific	antigen-specific	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	proliferation	proliferation	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	expansion	expansion	_	_	_	_	_	_	_
17	but	but	_	_	_	_	_	_	_
18	failed	fail	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	block	block	_	_	_	_	_	_	_
21	activation	activation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	Zap70	zap70	_	_	_	_	_	_	_
24	or	or	_	_	_	_	_	_	_
25	p56Lck	p56lck	_	_	_	_	_	_	_
26	after	after	_	_	_	_	_	_	_
27	anti-CD3	anti-cd3	_	_	_	_	_	_	_
28	stimulation	stimulation	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	human	human	_	_	_	_	_	_	_
31	T	t	_	_	_	_	_	_	_
32	cells	cell	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Taken	take	_	_	_	_	_	_	_
2	together	together	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	these	these	_	_	_	_	_	_	_
5	findings	finding	_	_	_	_	_	_	_
6	suggest	suggest	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	AG-490	ag-490	_	_	_	_	_	_	_
9	inhibits	inhibit	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	JAK3-mediated	jak3-mediated	_	_	_	_	_	_	_
12	Type	Type	_	_	_	_	_	_	_
13	II	ii	_	_	_	_	_	_	_
14	signaling	signaling	_	_	_	_	_	_	_
15	pathway	pathway	_	_	_	_	_	_	_
16	but	but	_	_	_	_	_	_	_
17	not	not	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	T	t	_	_	_	_	_	_	_
20	cell	cell	_	_	_	_	_	_	_
21	receptor-derived	receptor-derived	_	_	_	_	_	_	_
22	Type	Type	_	_	_	_	_	_	_
23	I	i	_	_	_	_	_	_	_
24	pathway	pathway	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	possesses	possess	_	_	_	_	_	_	_
27	therapeutic	therapeutic	_	_	_	_	_	_	_
28	potential	potential	_	_	_	_	_	_	_
29	for	for	_	_	_	_	_	_	_
30	T	t	_	_	_	_	_	_	_
31	cell-derived	cell-derived	_	_	_	_	_	_	_
32	pathologies	pathology	_	_	_	_	_	_	_
33	such	such	_	_	_	_	_	_	_
34	as	as	_	_	_	_	_	_	_
35	graft-versus-host	graft-versus-host	_	_	_	_	_	_	_
36	disease	disease	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	allergy	allergy	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	autoimmune	autoimmune	_	_	_	_	_	_	_
42	disorders	disorder	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

